Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for

Galila Mokhtar1, Amira Adly1, Ashraf Abdel Baky2,3,4

  • 1Pediatric Hematology and Oncology Unit, Department of Pediatrics, Ain Shams University, Cairo, Egypt.

Annals of Hematology
|February 22, 2024
PubMed

Insights

This study adapted existing guidelines for pediatric blood transfusions, creating a national clinical practice guideline (CPG) for safe transfusion in children. The CPG provides evidence-based recommendations for healthcare professionals across Egypt.

Area of Science:

  • Pediatric Hematology
  • Transfusion Medicine
  • Clinical Practice Guidelines

Background:

  • Pediatric transfusion practice lacks high-quality research compared to adult medicine.
  • Existing guidelines require adaptation for diverse pediatric age groups and national contexts.

Purpose of the Study:

  • To adapt existing high-quality transfusion guidelines for national use in Egypt.
  • To provide evidence-based recommendations for pediatric transfusion practices for healthcare professionals.

Main Methods:

  • Utilized the Adapted ADAPTE methodology for guideline adaptation.
  • Included a systematic search, quality appraisal, and contextual adaptation of recommendations.
  • Convened a panel of 17 Egyptian experts for guideline development.

Main Results:

  • Developed an adapted clinical practice guideline (CPG) covering indications, dosing, and administration of blood components.
  • Included recommendations for special pediatric situations, massive blood loss, and surgical transfusions.
  • Created implementation tools such as algorithms and flow charts to support clinical decision-making.

Conclusions:

  • The adapted CPG provides a valuable tool for safe transfusion practices in pediatric patients in Egypt.
  • Enhances evidence-based care for neonates, children, and young adults requiring blood transfusions.
  • Facilitates consistent and safe transfusion management across various pediatric age groups and clinical scenarios.

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
560
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
1.7K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330